Bacterial Endotoxin Testing (BET) is a critical quality control procedure used throughout the pharmaceutical, biotechnology, medical device, and healthcare industries.
Even small procedural errors can lead to invalid results, failed Product Positive Controls (PPCs), repeat testing, investigation costs, and regulatory concerns.
Below are 15 common endotoxin testing mistakes and how laboratories can avoid them.
Regular laboratory tubes, pipette tips, and microplates may introduce endotoxin contamination or adsorb endotoxin from samples.
Always use certified endotoxin-free consumables for BET applications.
Every product matrix must demonstrate that it does not interfere with endotoxin detection.
Failure to perform method suitability testing can result in unreliable endotoxin results.
Excessive dilution may reduce endotoxin concentrations below detectable levels.
Insufficient dilution may leave inhibitory substances present.
Both situations can compromise assay performance.
The MVD establishes the highest permissible sample dilution while maintaining assay sensitivity.
Testing beyond the MVD may invalidate results.
Calculation errors, inaccurate pipetting, or poor mixing can affect Product Positive Control recovery.
Always verify dilution calculations and preparation procedures.
A failed PPC often indicates assay interference.
Repeating the test without identifying the root cause may waste valuable time and resources.
Expired reagents may produce inconsistent results and increase assay variability.
Maintain a robust reagent inventory and monitoring system.
Improper storage conditions may affect reagent performance.
Follow manufacturer recommendations regarding temperature and storage requirements.
Inaccurate pipetting can significantly affect recovery calculations and endotoxin concentrations.
Regular pipette calibration and operator training are essential.
Extreme pH conditions can interfere with endotoxin detection reactions.
Verify pH requirements during method suitability studies.
Repeated freeze-thaw cycles may affect sample integrity and assay consistency.
Follow validated sample handling procedures.
Incomplete mixing can lead to uneven endotoxin distribution and inconsistent results.
Mix samples and endotoxin spikes thoroughly before analysis.
Incorrect incubation temperatures or timing can affect assay performance.
Ensure equipment is properly calibrated and monitored.
Extended delays may increase the risk of adsorption or degradation effects.
Prepare and test samples according to validated procedures.
Incomplete records can complicate investigations and regulatory audits.
Maintain clear and traceable laboratory documentation.
Laboratories can reduce failures and repeat testing by:
A proactive quality approach helps ensure accurate and reproducible endotoxin results.
Most endotoxin testing failures can be traced back to a small number of preventable laboratory mistakes. Proper training, validated procedures, suitable consumables, and effective troubleshooting can significantly improve assay reliability and compliance.
BIOENTAL supports laboratories with endotoxin method suitability studies, technical troubleshooting, recombinant endotoxin technologies, and endotoxin-free consumables to help ensure accurate and compliant BET results.
Recommended guides, troubleshooting resources, and validation insights for pharmaceutical, biotechnology, and medical device laboratories.
Need Assistance?